U.S. markets closed
  • S&P 500

    3,841.94
    +73.47 (+1.95%)
     
  • Dow 30

    31,496.30
    +572.16 (+1.85%)
     
  • Nasdaq

    12,920.15
    +196.68 (+1.55%)
     
  • Russell 2000

    2,192.21
    +45.29 (+2.11%)
     
  • Crude Oil

    66.28
    +2.45 (+3.84%)
     
  • Gold

    1,698.20
    -2.50 (-0.15%)
     
  • Silver

    25.30
    -0.17 (-0.65%)
     
  • EUR/USD

    1.1925
    -0.0054 (-0.45%)
     
  • 10-Yr Bond

    1.5540
    +0.0040 (+0.26%)
     
  • GBP/USD

    1.3827
    -0.0067 (-0.48%)
     
  • USD/JPY

    108.2450
    +0.2690 (+0.25%)
     
  • BTC-USD

    48,624.77
    +1,807.06 (+3.86%)
     
  • CMC Crypto 200

    982.93
    +39.75 (+4.21%)
     
  • FTSE 100

    6,630.52
    -20.36 (-0.31%)
     
  • Nikkei 225

    28,864.32
    -65.78 (-0.23%)
     

United States Osteoarthritis Market Report 2021: Epidemiology, Valuations And Forecast, Drugs Sales and Competitive Landscape 2017-2026 - ResearchAndMarkets.com

·2 min read

The "US Osteoarthritis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

US Osteoarthritis Market and Competitive Landscape Highlights - 2021, provides comprehensive insights into Osteoarthritis pipeline products, Osteoarthritis epidemiology, Osteoarthritis market valuations and forecast, Osteoarthritis drugs sales and competitive landscape in the US.

The research is classified into seven sections - Osteoarthritis treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:

  • Osteoarthritis pipeline: Find out the products in clinical trials for the treatment of Osteoarthritis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products

  • Osteoarthritis epidemiology: Find out the number of patients diagnosed (prevalence) with Osteoarthritis in the US

  • Osteoarthritis drugs: Identify key products marketed and prescribed for Osteoarthritis in the US, including trade name, molecule name, and company

  • Osteoarthritis drugs sales: Find out the sales revenues of Osteoarthritis drugs in the US

  • Osteoarthritis market valuations: Find out the market size for Osteoarthritis drugs in 2019 in the US. Find out how the market advanced from 2017 and forecast to 2026

  • Osteoarthritis drugs market share: Find out the market shares for key Osteoarthritis drugs in the US

Benefits of this Research:

  • Support monitoring and reporting national Osteoarthritis market analysis and sales trends

  • Track competitor drugs sales and market share in the US Osteoarthritis market

  • Track competitive developments in Osteoarthritis market and present key issues and learnings

  • Synthesize insights for Osteoarthritis market and products to drive business performance

  • Answer key business questions about the Osteoarthritis market

  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Osteoarthritis products

  • Supports decision making in R&D to long term marketing strategies

Key Topics Covered:

1) Osteoarthritis Treatments

2) Osteoarthritis Pipeline

3) US Osteoarthritis Epidemiology

4) Marketed Drugs for Osteoarthritis in US

5) US Osteoarthritis Market Size and Forecast

6) US Osteoarthritis Products Sales and Forecast

7) US Osteoarthritis Market Competitive Landscape

8) Methodology

For more information about this report visit https://www.researchandmarkets.com/r/jm84eb

View source version on businesswire.com: https://www.businesswire.com/news/home/20210205005442/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900